Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Interest Coverage Ratio (2020 - 2026)

Barinthus Biotherapeutics filings provide 7 years of Interest Coverage Ratio readings, the most recent being 467.31 for Q1 2026.

  • On a quarterly basis, Interest Coverage Ratio rose 70.51% to 467.31 in Q1 2026 year-over-year; TTM through Mar 2026 was 1098.63, a 17.21% increase, with the full-year FY2025 number at 1383.43, down 7.87% from a year prior.
  • Interest Coverage Ratio hit 467.31 in Q1 2026 for Barinthus Biotherapeutics, up from 889.62 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 8.84 in Q1 2022 to a low of 2855.43 in Q4 2023.
  • Median Interest Coverage Ratio over the past 5 years was 1523.83 (2024), compared with a mean of 1423.61.
  • Biggest five-year swings in Interest Coverage Ratio: soared 479.46% in 2022 and later plummeted 110.04% in 2025.
  • Barinthus Biotherapeutics' Interest Coverage Ratio stood at 8.84 in 2022, then crashed by 32409.13% to 2855.43 in 2023, then skyrocketed by 31.74% to 1949.17 in 2024, then soared by 54.36% to 889.62 in 2025, then surged by 47.47% to 467.31 in 2026.
  • The last three reported values for Interest Coverage Ratio were 467.31 (Q1 2026), 889.62 (Q4 2025), and 1158.92 (Q3 2025) per Business Quant data.